Bay Colony Advisory Group, Inc D Incyte Corp Transaction History

Bay Colony Advisory Group, Inc D

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$73.04 - $95.72 $679,272 - $890,196	-9,300 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$73.52 - $88.7 $29,408 - $35,480	-400 Reduced 4.12%	9,300 $790,000
Q4 2018 Jan 29, 2019	SELL	$58.5 - $69.94 $5,850 - $6,994	-100 Reduced 1.02%	9,700 $617,000
Q3 2018 Nov 05, 2018	SELL	$61.75 - $74.23 $43,225 - $51,961	-700 Reduced 6.67%	9,800 $677,000
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $638,925 - $881,790	10,500 New	10,500 $704,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.